Literature DB >> 3126354

Alterations in cholesterol metabolism in cultured fibroblasts from patients with Niemann-Pick disease type C.

C Mazière1, J C Mazière, L Mora, A Lageron, C Polonovski, J Polonovski.   

Abstract

Cholesterol synthesis, esterification and efflux were investigated in cultured fibroblasts from patients with Niemann-Pick disease type C. Sterol synthesis from sodium acetate was markedly increased in the two Niemann-Pick disease type C strains as compared to controls, either in the presence or absence of exogenous cholesterol supply by low-density lipoproteins. By contrast, cholesterol esterification was about 2-3-fold reduced when measured by oleic acid incorporation into cholesteryl esters and 10-15-fold reduced when measured with labelled free cholesterol as precursor, although acylcoenzyme-A:cholesterol acyltransferase activity was normal when studied in vitro on cell homogenates. Chase experiments with 14C-cholesterol demonstrated that the rate of cholesterol efflux was decreased by about 3-4-fold in fibroblasts from patients with Niemann-Pick disease type C. These results provide further evidence for alterations of sterol metabolism in Niemann-Pick disease type C and support the hypothesis of a trapping of exogenous cholesterol, which cannot enter the regulatory intracellular pools.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3126354     DOI: 10.1007/bf01799976

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

1.  Resolution of tissue sphingomyelinase isoelectric profile in multiple components is extraction-dependent: evidence for a component defect in Niemann-Pick disease type C is spurious.

Authors:  K Harzer; A P Anzil; I Schuster
Journal:  J Neurochem       Date:  1977-12       Impact factor: 5.372

2.  Rapid screening of lipid metabolism in monolayer cell cultures.

Authors:  E A Dosado; A W Hsie; F Snyder
Journal:  J Lipid Res       Date:  1976-05       Impact factor: 5.922

3.  Letters: A simple sphingomyelinase determination for Niemann-Pick disease: differential diagnosis of types A, B and C.

Authors:  K Harzer; H U Benz
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

4.  In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and C.

Authors:  J C Maziere; C Maziere; L Mora; J D Routier; J Polonovski
Journal:  Biochem Biophys Res Commun       Date:  1982-10-15       Impact factor: 3.575

5.  A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.

Authors:  A E Gal; R O Brady; S R Hibbert; P G Pentchev
Journal:  N Engl J Med       Date:  1975-09-25       Impact factor: 91.245

6.  Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

7.  Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.

Authors:  H Christomanou
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-10

8.  Sphingomyelinase activities of various human tissues in control subjects and in Niemann-Pick disease - development and evaluation of a microprocedure.

Authors:  M T Vanier; A Revol; M Fichet
Journal:  Clin Chim Acta       Date:  1980-10-09       Impact factor: 3.786

9.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.

Authors:  P G Pentchev; M E Comly; H S Kruth; M T Vanier; D A Wenger; S Patel; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Cholesterol and 7-dehydrocholesterol inhibit the in situ degradation of sphingomyelin by cultured human fibroblasts.

Authors:  J C Mazière; C Mazière; L Mora; F Gallie; J Polonovski
Journal:  Biochem Biophys Res Commun       Date:  1983-05-16       Impact factor: 3.575

View more
  6 in total

1.  Storage by excessive blood cell destruction or due to Niemann-Pick disease type C: an ambiguous case.

Authors:  A Lageron; J C Mazière; P Gane; D Goossens; C Roy
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Effects of dietary cholesterol restriction in a feline model of Niemann-Pick type C disease.

Authors:  K L Somers; D E Brown; R Fulton; P C Schultheiss; D Hamar; M O Smith; R Allison; H E Connally; C Just; T W Mitchell; D A Wenger; M A Thrall
Journal:  J Inherit Metab Dis       Date:  2001-08       Impact factor: 4.982

3.  Type C Niemann-Pick disease fibroblasts and their transformed cell lines are hypersensitive to HMG-CoA reductase inhibitors.

Authors:  T Yamamoto; T Ohashi; T Tokoro; K Maekawa; Y Eto
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media.

Authors:  G H Thomas; C M Tuck-Muller; C S Miller; L W Reynolds
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

Review 5.  Niemann-Pick disease type C: an update.

Authors:  M T Vanier; P Pentchev; C Rodriguez-Lafrasse; R Rousson
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 6.  Understanding and Treating Niemann-Pick Type C Disease: Models Matter.

Authors:  Valentina Pallottini; Frank W Pfrieger
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.